Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi has published its financial report for the first half of 2026, available on its website and filed with the French financial authority (AMF). The biopharmaceutical company highlights its innovation in R&D and use of AI to drive long-term growth and improve global health. The report underscores Sanofi's commitment to developing medicines and vaccines that address urgent health challenges worldwide. Investors can access detailed financial data and company updates through the official investor relations channels.